Over the last 12 months, Immunovant insiders reported no purchases and 17 sales totaling $15.0M across SEC Form 4 filings. 18% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Pande AtulD | ▼ Sale | 1,500 | $39.8 | $60K | -1.3% | plan |
| Jul 23, 2026 | Girao TiagoChief Financial Officer · O | ▼ Sale | 6,798 | $38.69 | $263K | -2.7% | — |
| Jul 23, 2026 | Stout Jay SChief Technology Officer · O | ▼ Sale | 2,857 | $38.69 | $111K | -1.4% | — |
| Jul 8, 2026 | Gloria MelanieChief Operating Officer · O | ▼ Sale | 2,036 | $39.55 | $81K | -0.9% | 2 tranches |
| Jul 8, 2026 | Van Tuyl ChristopherChief Legal Officer · O | ▼ Sale | 1,206 | $39.55 | $48K | -0.7% | 2 tranches |
| Jul 8, 2026 | Stout Jay SChief Technology Officer · O | ▼ Sale | 3,487 | $39.55 | $138K | -1.6% | 4 tranches |
| Jul 2, 2026 | Venker EricChief Executive Officer · O·D | ▼ Sale | 3,092 | $38.48 | $119K | -1.2% | — |
| Jul 1, 2026 | Venker EricChief Executive Officer · O·D | ▽ Sale to issuer | 86,629 | $38.14 | $3.3M | -25.2% | — |
| Jun 26, 2026 | Gloria MelanieChief Operating Officer · O | ▼ Sale | 17,714 | $38.31 | $679K | -7.3% | 2 tranches |
| Jun 26, 2026 | Stout Jay SChief Technology Officer · O | ▼ Sale | 40,000 | $38.31 | $1.5M | -15.9% | 2 tranches |
| Jun 26, 2026 | Van Tuyl ChristopherChief Legal Officer · O | ▼ Sale | 17,824 | $38.31 | $683K | -9% | 2 tranches |
| Jun 26, 2026 | Girao TiagoChief Financial Officer · O | ▼ Sale | 10,000 | $38.46 | $385K | -3.9% | — |
| Jun 26, 2026 | Pande AtulD | ▼ Sale | 1,500 | $38.01 | $57K | -1.3% | plan |
| Jun 18, 2026 | Van Tuyl ChristopherChief Legal Officer · O | ▼ Sale | 2,634 | $35.39 | $93K | -1.4% | — |
| Jun 15, 2026 | Pande AtulD | ▼ Sale | 1,500 | $34.02 | $51K | -1.3% | plan |
| May 28, 2026 | Fromkin Andrew J.D | ▼ Sale | 210,468 | $33.56 | $7.1M | -73.9% | — |
| May 28, 2026 | Fromkin Andrew J.D | ▼ Sale | 11,483 | $32.64 | $375K | -3.9% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IMVT feed.